🕵️ Obsidian Therapeutics, Inc. ($OBX)
SEC insider & ownership activity, last 12 months · CIK 2130606 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| RA Capital Management, L.P. | 9.7% | 13G | Aug 10, 2026 | filing ↗ | |
| Peter Kolchinsky | 9.7% | 13G | Aug 10, 2026 | filing ↗ | |
| Rajeev Shah | 9.7% | 13G | Aug 10, 2026 | filing ↗ | |
| RA Capital Healthcare Fund, L.P. | 8.0% | 13G | Aug 10, 2026 | filing ↗ | |
| DEEP Track Capital, LP | 5.4% | 13G | Aug 11, 2026 | filing ↗ | |
| David Kroin | 5.4% | 13G | Aug 11, 2026 | filing ↗ | |
| NOVO Holdings A/S | 5.1% | 13G | Aug 10, 2026 | filing ↗ | |
| DEEP Track Biotechnology Master Fund, Ltd. | 5.1% | 13G | Aug 11, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Financial Statements and Exhibits (9.01) | Jul 31, 2026 | filing ↗ |
| Material agreement (1.01) | Jul 31, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | Jul 31, 2026 | filing ↗ |
| Earnings (2.02) | Jul 31, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jul 31, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Jul 31, 2026 | filing ↗ |
| Auditor change (4.01) | Jul 31, 2026 | filing ↗ |
| Change of control (5.01) | Jul 31, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jul 31, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jul 31, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 31, 2026 | filing ↗ |